FORT LAUDERDALE, Fla., Jan. 23 /PRNewswire-FirstCall/ -- Imaging Diagnostic Systems, Inc. will exhibit an array of CT laser breast imaging clinical results at Arab Health 2006, January 22-25 in Dubai, United Arab Emirates. IDSI will be located at stand 2G41.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO )
“Arab Health is an important event for us,” commented Janusz Ostrowski, VP of International Sales at Imaging Diagnostic Systems. “Through our attendance, we are reinforcing the clinical value of CTLM(R) breast exams to women in the Middle East and supporting our customers in the region. At the upcoming session, we will present clinical CT Laser Mammography cases compared to mammography, ultrasound, and MRI from a number of our luminary sites.”
Featuring concurrent specialist conferences, Arab Health is the largest healthcare exhibition in the Middle East. In 2005, over 28,000 visitors attended.
The CTLM(R) system is the first patented breast imaging system that utilizes state-of-the-art laser technology and patented algorithms to create 3-D cross-sectional images of the breast. It is a non-invasive, painless examination that does not expose the patient to radiation or require breast compression. Imaging Diagnostic Systems has received CE Marking, CMDCAS (Canada), Canadian License, China SFDA approval, UL listing, ISO 9001:2000-13488 certification and FDA export certification for its CT Laser Breast Imaging system. The Company is seeking PreMarket Approval (PMA) from the Food and Drug Administration (FDA) for its CTLM(R) system to be used as an adjunct to mammography.
Please visit Imaging Diagnostic Systems’ website at: http://www.imds.com for additional information.
In conjunction with the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future anticipated projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates of future results and there can be no assurance that actual results will not materially differ from expectation. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc. is included in the Company’s filing with the Securities Exchange Commission.
Investor Relations: Rick Lutz 404-261-1196 lcgroup@mindspring.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comImaging Diagnostic Systems, Inc.
CONTACT: Investors, Rick Lutz, +1-404-261-1196, or lcgroup@mindspring.com,for Imaging Diagnostic Systems
Web site: http://www.imds.com//